RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2006(16): 2738-2742
DOI: 10.1055/s-2006-942494
DOI: 10.1055/s-2006-942494
PAPER
© Georg Thieme Verlag Stuttgart · New York
Synthesis of 2-Selenoxoperhydro-1,3-selenazin-4-ones and 2-Selenoxo-1,3-selenazolidin-4-ones via Diselenocarbamate Intermediates
Weitere Informationen
Received
27 March 2006
Publikationsdatum:
13. Juli 2006 (online)
Publikationsverlauf
Publikationsdatum:
13. Juli 2006 (online)
Abstract
The treatment of substituted acryloyl isoselenocyanates with sodium hydroselenide gave 2-selenoxoperhydro-1,3-selenazin-4-ones. The reaction of diselenocarbamates, generated from alkyl isoselenocyanates and sodium hydroselenide, with bromoacetyl bromide afforded 2-selenoxo-1,3-selenazolidin-4-ones.
Key words
isoselenocyanate - diselenocarbamate - selenazine - selenazole - sodium hydroselenide
-
1a
Comprehensive Heterocyclic Chemistry II
Vols. 1-11:
Katritzky AR.Rees CW.Scriven EFV. Pergamon; Oxford: 1996. -
1b
Back TG. Organoselenium Chemistry: A Practical Approach Oxford University Press; Oxford: 1999. -
1c
Organoselenium Chemistry. Modern Developments in Organic Synthesis, In Topics in Current Chemistry
Vol. 208:
Wirth T. Springer; Heidelberg: 2000. -
1d
Murai T.Kato S. Top. Curr. Chem. 2000, 208: 177 -
1e
Ishihara H.Koketsu M.Fukuta Y.Nada F. J. Am. Chem. Soc. 2001, 123: 8408 -
2a
Koketsu M.Ishihara H.Wu W.Murakami K.Saiki I. Eur. J. Pharm. Sci. 1999, 9: 157 -
2b
Wu W.Murakami K.Koketsu M.Yamada Y.Saiki I. Anticancer Res. 1999, 19: 5375 -
2c
Cho SI.Koketsu M.Ishihara H.Matsushita M.Nairn AC.Fukazawa H.Uehara Y. Biochim. Biophys. Acta 2000, 1475: 207 -
2d
Koketsu M.Choi SY.Ishihara H.Lim BO.Kim H.Kim SY. Chem. Pharm. Bull. 2002, 50: 1594 -
2e
Gutzkow KB.Låhne HU.Naderi S.Torgersen KM.Skålhegg B.Koketsu M.Uehara Y.Blomhoff HK. Cell. Signal. 2003, 15: 871 - 3
Park Y.-J.Koketsu M.Kim JM.Yeo J.-H.Ishihara H.Lee K.-G.Kim SY.Kim C.-K. Biol. Pharm. Bull. 2003, 26: 1657 -
4a
Koketsu M.Takenaka Y.Ishihara H. Synthesis 2001, 731 -
4b
Zhang P.-F.Chen Z.-C. Synthesis 2000, 1219 -
4c
Koketsu M.Senda T.Yoshimura K.Ishihara H. J. Chem. Soc., Perkin Trans. 1 1999, 453 -
4d
Lai LL.Reid DH. Synthesis 1993, 870 -
4e
Moriarty RM.Vaid BK.Duncan MP.Levy SG.Prakash O.Goyal S. Synthesis 1992, 845 -
4f
Shimada K.Matsuda Y.Hikage S.Takeishi Y.Takikawa Y. Bull. Chem. Soc. Jpn. 1991, 64: 1037 -
4g
Shafiee A.Shafaati A.Habibi-Khameneh B. J. Heterocycl. Chem. 1989, 26: 709 -
4h
Cohen VI. Synthesis 1979, 66 -
4i
Potts KT.Huang F.Khattak RK. J. Org. Chem. 1977, 42: 1644 -
4j
Cava MP.Saris LE. J. Chem. Soc., Chem. Commun. 1975, 617 -
5a
Sommen GL.Linden A.Heimgartner H. Eur. J. Org. Chem. 2005, 3128 -
5b
Atanassov PK.Linden A.Heimgartner H. Helv. Chim. Acta 2004, 87: 1452 -
5c
Atanassov PK.Linden A.Heimgartner H. Helv. Chim. Acta 2003, 86: 3235 -
5d
Billert T.Beckert R.Doring M.Gorls H. J. Prakt. Chem. 1999, 341: 332 -
5e
Banert K.Toth C. Angew. Chem., Int. Ed. Engl. 1995, 34: 1627 -
6a
Sommen GL.Linden A.Heimgartner H. Heterocycles 2005, 65: 1903 -
6b
Zhou Y.Heimgartner H. Helv. Chim. Acta 2000, 83: 539 -
6c
Kanda T.Aoki H.Mizoguchi K.Shiraishi S.Murai T.Kato S. Organometallics 1996, 15: 5753 -
7a
Koketsu M.Fukuta Y.Ishihara H. J. Org. Chem. 2002, 67: 1008 -
7b
Koketsu M.Ishida M.Takakura N.Ishihara H. J. Org. Chem. 2002, 67: 486 -
7c
Koketsu M.Nada F.Hiramatsu S.Ishihara H. J. Chem. Soc., Perkin Trans. 1 2002, 737 -
7d
Koketsu M.Fukuta Y.Ishihara H. Tetrahedron Lett. 2001, 42: 6333 -
7e
Ishihara H.Koketsu M.Fukuta Y.Nada F. J. Am. Chem. Soc. 2001, 123: 8408 -
8a
Thompson DP.Boudjouk P. J. Org. Chem. 1988, 53: 2109 -
8b
Klayman DL.Griffin TS. J. Am. Chem. Soc. 1973, 95: 197 -
8c
Gladysz JA.Hornby JL.Garbe JE. J. Org. Chem. 1978, 43: 1204 - 9 This structure is novel. There is only one example of preparation of pyrido[3,2-e]-1,3-selenazine and pyrido[3,4-e]-1,3-selenazine ring compounds, see:
Kristian P.Koscik D.Gonda J. Collect. Czech. Chem. Commun. 1983, 48: 3567 - Two patents regarding 2-thioxo-1,3-selenazolidin-4-one have appeared see, (a) and (b), while (b) also reports 2-selenoxo-1,3-selenazolidin-4-ones:
-
10a
Suga T,Mine K,Takahashi Y, andFujimori N. inventors; JP 50071325. ; Chem. Abstr. 1976, 52086 -
10b
Sieglitz A, andHeimke P. inventors; DE 700555. -
12a
Casar Z.Leban I.Majcen-Le Marechal A.Lorcy D. J. Chem. Soc., Perkin Trans. 1 2002, 1568 -
12b
Koketsu M.Nada F.Ishihara H. Synthesis 2002, 195 -
12c
Brown GA.Anderson KMM.Murray KM.Gallagher T.Hales NJ. Tetrahedron 2000, 56: 5579 -
12d
Cruz A.Macias-Mendoza D.Barragan-Rodriguez E.Tlahuext H.Noth H.Contreras R. Tetrahedron: Asymmetry 1997, 8: 3903
References
CCDC 298139 for 4a contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336033.